Moderna Shares Jump After Company Confirms Hantavirus Vaccine Research
Moderna Inc. confirmed it is conducting early-stage research on vaccines targeting hantaviruses, collaborating with the U.S. Army Medical Research Institute of Infectious Diseases and the Vaccine Innovation Center at Korea University College of Medicine. The announcement coincided with a 16% surge in the company’s shares and follows a recent outbre…